International Dermatology Outcome Measures Logo

MIP Score

53

Med Research
Medical Research Advocacy

International Dermatology Outcome Measures

Mission

International Dermatology Outcome Measures (IDEOM) is dedicated to developing evidence-based outcome measures to evaluate the impact of treatments for patients with dermatological diseases. By creating standardized measures, IDEOM aims to improve patient access to effective therapies, guide treatment recommendations, and inform payers regarding the efficacy of treatments.

Basic Information

Tax-Exempt

Address

1100 Melody Ln, Roseville, California, 95678

View all Roseville charities

Founded in

2013

EIN

46-3494056

Total Assets

$2.508 million

At a Glance

Bringing Stakeholders Together

Bringing Stakeholders Together

IDEOM connects diverse stakeholders to establish patient-centered measurements.

12th Annual Meeting

12th Annual Meeting

Join us for the IDEOM 12th Annual Meeting on June 27-28, 2025, in Washington, DC.

Recent Awards

Recent Awards

Dr. Alice B. Gottlieb received the 2023 Master Dermatologist Award.

Upcoming Events

AID 2025 Dermatology Summit

AID 2025 Dermatology Summit

2025-01-12

Join us for the AID 2025 Dermatology Summit on January 12, 2025, in San Francisco, CA.

Learn More
9th Münster Pruritus Hybrid Symposium

9th Münster Pruritus Hybrid Symposium

2024-09-20

Attend the hybrid symposium on pruritus on September 20-21, 2024.

Learn More
IDEOM 12 Annual Meeting

IDEOM 12 Annual Meeting

2025-06-27

IDEOM's 12th Annual Meeting from June 27-28, 2025, featuring crucial discussions on dermatology outcomes.

Learn More

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

53

44

/100

Program Expense Ratio

88.24%

20

/20

Program Revenue Growth

-68.75%

2

/20

Leverage Ratio

0

2

/20

Working Capital Ratio

6.107

18

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants520K90.52%
Program Services2.5K0.44%
Investment Income3.463K0.60%
Sales of Non-Inventory Assets00.00%
Other Notable Sources5000.09%
Total Revenue574.4K100.00%